Task: Answer the multiple choice question.
Question: Which compound exhibits a -0.277\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CC(C)c1ccc(S(=O)(=O)N2CCC(C(=O)N3CCC3)CC2)cc1
b) O=C(N/N=C/c1cccn1-c1ccc([N+](=O)[O-])cc1)C(O)c1ccccc1
Answer: b. O=C(N/N=C/c1cccn1-c1ccc([N+](=O)[O-])cc1)C(O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(N/N=C/c1cccn1-c1ccc([N+](=O)[O-])cc1)C(O)c1ccccc1
O=C(N/N=C/c1cccn1-c1ccc([N+](=O)[O-])cc1)C(O)c1ccccc1
2-hydroxy-N-[(E)-[1-(4-nitrophenyl)pyrrol-2-yl]methylideneamino]-2-phenylacetamide